{{Rsnum
|rsid=7191888
|Chromosome=16
|position=73547159
|Orientation=plus
|GMAF=0.1878
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=LOC101927998
|Gene_s=LOC101927998
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 70.8 | 24.8 | 4.4
| HCB | 72.3 | 26.3 | 1.5
| JPT | 83.2 | 16.8 | 0.0
| YRI | 41.5 | 39.5 | 19.0
| ASW | 47.4 | 47.4 | 5.3
| CHB | 72.3 | 26.3 | 1.5
| CHD | 78.9 | 19.3 | 1.8
| GIH | 53.5 | 41.6 | 5.0
| LWK | 37.6 | 46.8 | 15.6
| MEX | 56.9 | 41.4 | 1.7
| MKK | 38.5 | 46.2 | 15.4
| TSI | 68.6 | 29.4 | 2.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (severity)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000006
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs7191888
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR); (Region: 16q22.3; Reported Gene(s): C16orf47; Risk Allele: rs7191888-?); (p-value= 0.000006).This variant is associated with Multiple sclerosis (severity).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740727
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7191888
|overall_frequency_n=35
|overall_frequency_d=128
|overall_frequency=0.273438
|n_genomes=25
|n_genomes_annotated=0
|n_haplomes=28
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}